Interestingly, in KRAS wild-type cell lines derived from colorectal cancer, inhibition of EGFR signalling was less effective in 3D cultures grown in laminin-rich extracellular matrices, emphasizing the influence of the ECM on cancer growth and drug response [157]. The gene discussed is EGFR; the disease is cancer.